OKUR(OnKure Therapeutics, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-21 | Leverone Jason A. | Chief Financial Officer | 公开市场卖出 | 302 | $2.97 |
| 2026-09-21 | Saccomano Nicholas A | President and CEO | 公开市场卖出 | 87 | $2.97 |
| 2026-06-22 | Leverone Jason A. | Chief Financial Officer | 公开市场卖出 | 303 | $4.40 |
| 2026-06-22 | Saccomano Nicholas A | President and CEO | 公开市场卖出 | 86 | $4.40 |
| 2026-03-23 | Leverone Jason A. | Chief Financial Officer | 公开市场卖出 | 301 | $4.16 |
| 2026-03-23 | Saccomano Nicholas A | President and CEO | 公开市场卖出 | 86 | $4.16 |
| 2025-12-22 | Leverone Jason A. | Chief Financial Officer | 公开市场卖出 | 302 | $2.97 |
| 2025-12-22 | Saccomano Nicholas A | President and CEO | 公开市场卖出 | 87 | $2.97 |
| 2025-09-22 | Leverone Jason A. | Chief Financial Officer | 公开市场卖出 | 303 | $2.62 |
| 2025-09-22 | Saccomano Nicholas A | President and CEO | 公开市场卖出 | 88 | $2.62 |
| 2025-06-23 | Saccomano Nicholas A | President and CEO | 公开市场卖出 | 88 | $2.38 |
| 2025-06-23 | Leverone Jason A. | Chief Financial Officer | 公开市场卖出 | 303 | $2.38 |
| 2025-05-15 | ACORN BIOVENTURES, L.P. | 10% 股东 | 公开市场买入 | 1,129,730 | $1.85 |
| 2025-05-15 | ACORN BIOVENTURES, L.P. | 10% 股东 | 公开市场买入 | 270,270 | $1.85 |
| 2025-05-15 | Cormorant Asset Management, LP | Former 10% Owner | 公开市场卖出 | 1,813,439 | $1.85 |
| 2025-05-12 | Cormorant Asset Management, LP | 10% 股东 | 公开市场卖出 | 24,300 | $1.99 |
| 2025-04-07 | Saccomano Nicholas A | President and CEO | 公开市场卖出 | 516 | $2.67 |
| 2025-04-07 | Leverone Jason A. | Chief Financial Officer | 公开市场卖出 | 1,844 | $2.67 |
| 2025-04-04 | Saccomano Nicholas A | President and CEO | 公开市场卖出 | 358 | $3.33 |
| 2025-04-04 | Leverone Jason A. | Chief Financial Officer | 公开市场卖出 | 1,278 | $3.33 |